Effect of low-fat vegetable butter enriched with peribiotic on the level of blood lipid factors, liver enzymes, and immune system function

Study of the effect of consuming low-fat vegetable butter enriched with resistant starch on the level of blood lipid factors, liver enzymes, and immune system function in 30-60 years adults - A Triple-blinded, randomized clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160117026069N8

Enrollment

Registered

2023-12-03

Start date

2023-11-29

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Hyperlipidemia. Condition 2: Hypercholesterolemia. Condition 3: Hyperglycemia. Condition 4: High level of liver enzymes. Condition 5: Level of Abs. Hyperlipidemia, unspecified

Interventions

Intervention 1: Control group: Daily consumption of 50 grams of low fat vegetable butter without resistant starch made by Mahgol factory for six weeks with each meal as desired by the participant. Int

Eligibility

Sex/Gender

All

Age

30 Years to 60 Years

Inclusion criteria

Inclusion criteria: between 30-60 years old BMI below 30

Exclusion criteria

Exclusion criteria: History of hyperlipidemia History of high blood cholesterol Cardiovascular diseases Diabetes Liver diseases Kidney diseases Underlying and chronic diseases Allergy to vegetable butter Allergy to additives Digestive disorders

Design outcomes

Primary

Measure	Time frame
Total Cholestrol. Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.	—

Secondary

Measure	Time frame
HDL (High Density Lipoprotein) Cholesterol. Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;LDL (Low Density Lipoprotein) Cholesterol. Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;Triglyceride. Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;Serum Glutamic Oxaloacetic Transaminase (SGOT). Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;Serum Glutamic Pyruvic Transaminase (SGPT). Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;Alkaline Phosphatase (ALP). Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;IgA. Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;IgM. Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;IgG. Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;HbA1C. Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;Fasting Blood Sugar (FBS). Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.	—

Measure

Time frame

HDL (High Density Lipoprotein) Cholesterol. Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;LDL (Low Density Lipoprotein) Cholesterol. Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;Triglyceride. Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;Serum Glutamic Oxaloacetic Transaminase (SGOT). Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;Serum Glutamic Pyruvic Transaminase (SGPT). Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;Alkaline Phosphatase (ALP). Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;IgA. Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;IgM. Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;IgG. Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;HbA1C. Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.;Fasting Blood Sugar (FBS). Timepoint: Before intervention, 6 weeks after intervention. Method of measurement: Use a lab kit.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHadi Pourjafar

Karaj University of Medical Sciences

pourjafarhadi59@gmail.com+98 26 3464 3705

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Aug 5, 2026